TY - JOUR T1 - COVID-19 Vaccination Priority Evaluation JF - medRxiv DO - 10.1101/2021.02.27.21252569 SP - 2021.02.27.21252569 AU - Jozo Dujmović AU - Daniel Tomasevich Y1 - 2021/01/01 UR - http://medrxiv.org/content/early/2021/03/01/2021.02.27.21252569.abstract N2 - Computing the COVID-19 vaccination priority is an urgent and ubiquitous decision problem. In this paper we propose a solution of this problem using the LSP evaluation method. Our goal is to develop a justifiable and explainable quantitative criterion for computing a vaccination priority degree for each individual in a population. Performing vaccination in the order of the decreasing vaccination priority produces maximum positive medical, social, and ethical effects for the whole population. The presented method can be expanded and refined using additional medical and social conditions. In addition, the same methodology is suitable for solving other similar medical priority decision problems, such as priorities for organ transplants.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialThe paper proposes decision methodology. This study is not related to clinical trials.Funding StatementThis research is performed without external funding.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This contribution is in the area of informatics and it is not subject to formal approval of ethics committees. There are no patients involved and no clinical trials. We propose a decision method for evaluation of vaccination priority that is fully consistent with CDC recommendations. Of course, CDC recommendations are ethically verified before their publication, and or paper satisfies the same ethical standards.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe manuscript includes a full disclosure of all data we used in our examples. http://www.seas.com/LSPNT/login.php ER -